5-Methyl-1-(1-(3-(m-tolyloxy)benzyl)piperidin-4-yl)pyrimidine-2,4(1H,3H)-dione

ID: ALA4876042

PubChem CID: 164627230

Max Phase: Preclinical

Molecular Formula: C24H27N3O3

Molecular Weight: 405.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(Oc2cccc(CN3CCC(n4cc(C)c(=O)[nH]c4=O)CC3)c2)c1

Standard InChI:  InChI=1S/C24H27N3O3/c1-17-5-3-7-21(13-17)30-22-8-4-6-19(14-22)16-26-11-9-20(10-12-26)27-15-18(2)23(28)25-24(27)29/h3-8,13-15,20H,9-12,16H2,1-2H3,(H,25,28,29)

Standard InChI Key:  VEUQBKXFERTJQH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   14.0394  -29.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0383  -30.6635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7463  -31.0725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4560  -30.6630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4531  -29.8404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7445  -29.4351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1643  -31.0705    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8714  -30.6608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5800  -31.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2866  -30.6617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2857  -29.8437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5724  -29.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8687  -29.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9947  -31.0696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7020  -30.6602    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4094  -31.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1146  -30.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1179  -29.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4099  -29.4399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6986  -29.8474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8267  -29.4432    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5325  -29.8579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2392  -29.4547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2456  -28.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5392  -28.2245    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8263  -28.6294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9442  -29.8679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9559  -28.2332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1199  -28.2184    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3302  -31.0715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 10 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  1  0
 24 28  2  0
 26 29  2  0
  2 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4876042

    ---

Associated Targets(Human)

MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tmk Thymidylate kinase (360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2052AlogP: 3.78#Rotatable Bonds: 5
Polar Surface Area: 67.33Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.32CX Basic pKa: 8.03CX LogP: 3.53CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.70Np Likeness Score: -1.01

References

1. Song L, Merceron R, Hulpia F, Lucía A, Gracia B, Jian Y, Risseeuw MDP, Verstraelen T, Cos P, Aínsa JA, Boshoff HI, Munier-Lehmann H, Savvides SN, Van Calenbergh S..  (2021)  Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.,  225  [PMID:34450493] [10.1016/j.ejmech.2021.113784]

Source